Dexcel Pharma is an international, research-based, specialty healthcare group, dedicated to the discovery, development, manufacture and marketing of innovative drug formulations of successful established molecules.

Dexcel Pharma’s products – for the treatment of gastroenterological, cardiovascular, and central nervous system diseases – are based on its 9 unique, modified-release, drug delivery technologies and 22 groups of patents.

Dexcel Pharma also develops and  manufactures a broad range of controlled-release and difficult-to-manufacture or develop generic products for worldwide distribution.

Dexcel Pharma's R&D activities are fully-funded by its generic business.

Print

© All Rights Reserved to Dexcel Ltd.

Another site by | Graphic Design OneGroup | Developed by CodeOasis |